Items tagged with Scientific research
Consortium seeks to provide centralized access to global TB data for research, diagnostic development (post)
NEW YORK, Oct 08, 2015 -- An international team of investigators from various academic institutions, public health agencies, and nongovernmental organizations is developing a cloud-based repository of global tuberculosis data to support improved diagnostic development and clinical decision making.
Drug discovery to treat tuberculosis (post)
In a news feature article on the University of Cambridge web site Tom Blundell and colleagues discuss their research on tuberculosis and the progress in their partnership with India.
Tulane researchers working on new tuberculosis vaccine (post)
Researchers at the Tulane National Primate Research Center (TNPRC) are leading efforts to find a new vaccine for tuberculosis, one of the world’s deadliest diseases. Tuberculosis, a contagious infection of the lungs, affected more than nine million people in 2013, killing more than one million.
Center for Infectious Disease Research - GlaxoSmithKline partnership identifies potential for new tuberculosis treatments (post)
SEATTLE, October 13, 2015--Scientists at the Center for Infectious Disease Research, the largest independent nonprofit in the U.S. focused solely on infectious disease research, partnered with the Tres Cantos Open Lab Foundation at global pharmaceutical company GlaxoSmithKline to advance critically-needed treatments for Mycobacterium tuberculosis (Mtb). The research conducted through the partnership indicates that antifolates may be a candidate for continued tuberculosis drug discovery.
RESIST-TB Clinical Trials Progress Report: clinical trials for drug-resistant TB (post)
Visit the RESIST-TB Clinical Trials Progress Report to check out what trials are in development, enrolling and completed. The Clinical Trials Progress Report is available as a PDF here.
Deakin researchers discover potential treatment for tuberculosis (post)
Deakin University scientists have discovered a potential new treatment for tuberculosis, a disease rapidly gaining resistance against current medical therapies.
Study reveals structure of tuberculosis enzyme, could offer drug target (post)
A team of scientists, including several from the U.S. Department of Energy’s Argonne National Laboratory, have determined the structures of several important tuberculosis enzymes, which could lead to new drugs for the disease.
GHIT Fund invests $10.7 million to fight TB, malaria, leishmaniasis and dengue (post)
November 5, 2015 - The Global Health Innovative Technology Fund (GHIT Fund), which in the last two years has invested US$43 million to develop innovative tools for fighting diseases worldwide, today announced it is investing $10.7 million* at multiple points in the product development pipeline to seek new interventions for malaria, tuberculosis (TB), leishmaniasis and dengue.
Why new antibiotics never come to market (post)
In the murky depths of Lake Michigan, around 15 feet below the surface, Brian Murphy is examining the various thickets of seaweed and vibrantly coloured sponges clinging to the sides of an old wooden cargo ship.
Study sheds light on why parasite makes TB infections worse (post)
Scientists have shown how a parasitic worm infection common in the developing world increases susceptibility to tuberculosis. The study demonstrated that treating the parasite reduces lung damage seen in mice that also are infected with tuberculosis, thereby eliminating the vulnerability to tuberculosis (TB) that the parasite is known to cause.
Page 12 of 74 · Total posts: 0
←First 11 12 13 Last→